{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,28]],"date-time":"2026-09-28T03:15:45Z","timestamp":1790565345056,"version":"4.1.0"},"reference-count":34,"publisher":"American Society of Tropical Medicine and Hygiene","issue":"1","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2026,1,7]]},"abstract":"<jats:title>ABSTRACT.<\/jats:title>\n                  <jats:p>Tuberculosis (TB) remains a leading cause of morbidity and mortality in sub-Saharan Africa. Community pharmacies, which are often the first point of contact for people with TB, are underutilized in expanding TB care. Engaging community pharmacies in TB care could facilitate personalized adherence counseling, the timely detection and reporting of medication side effects, and the integration of TB and HIV services for individuals with both TB and HIV. Pharmacies can reduce stigma and address social and psychological barriers by offering person-centered care in convenient, accessible settings, including for working people and hard-to-reach communities. Integrating community pharmacies into national TB programs could strengthen adherence, reduce loss to follow-up, improve case detection, and help achieve End TB Strategy goals. The authors of the present study advocate for deliberate policy, training, and data linkages to realize this scalable opportunity, including implementation research.<\/jats:p>","DOI":"10.4269\/ajtmh.25-0477","type":"journal-article","created":{"date-parts":[[2025,11,6]],"date-time":"2025-11-06T17:04:04Z","timestamp":1762448644000},"page":"3-5","source":"Crossref","is-referenced-by-count":1,"title":["Missed Opportunities in Engaging Community Pharmacies for Integrated Tuberculosis Care in Sub-Saharan Africa: A Call to Action"],"prefix":"10.4269","volume":"114","author":[{"given":"Jonathan","family":"Izudi","sequence":"first","affiliation":[{"name":"Infectious Diseases Institute, Makerere University, Kampala, Uganda;"},{"name":"Directorate of Graduate Training, Research and Innovation, Muni University, Arua, Uganda;"},{"name":"Department of Community Health, Mbarara University of Science and Technology, Mbarara, Uganda;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christine","family":"Sekaggya-Wiltshire","sequence":"additional","affiliation":[{"name":"Infectious Diseases Institute, Makerere University, Kampala, Uganda;"},{"name":"Mulago National Referral and Specialized Hospital, Kampala, Uganda;"},{"name":"School of Medicine, St. Andrews University, Fife, United Kingdom;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Adithya","family":"Cattamanchi","sequence":"additional","affiliation":[{"name":"Division of Pulmonary Diseases and Critical Care Medicine, University of California Irvine, Irvine, California;"},{"name":"Center for Tuberculosis, Institute for Global Health Sciences, University of California San Francisco, San Francisco, California"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"2795","reference":[{"key":"b1","series-title":"Arch Bronconeumol","first-page":"446","article-title":"Tuberculosis-HIV co-infection: Progress and challenges after two decades of global antiretroviral treatment roll-out","volume":"56","author":"Letang","year":"2020"},{"key":"b2","series-title":"J Pharm Policy Pract","first-page":"6","article-title":"Engagement of the private pharmaceutical sector for TB control: Rhetoric or reality?","volume":"10","author":"Konduri","year":"2017"},{"key":"b3","series-title":"Curr HIV\/AIDS Rep","first-page":"2","article-title":"Feasibility and impact of community pharmacy and novel pick-up points for antiretroviral therapy pre-exposure prophylaxis initiation and continuation in low and middle-income countries","volume":"22","author":"Lalla-Edward","year":"2024"},{"key":"b4","series-title":"PLoS One","first-page":"e0269020","article-title":"Client and healthcare worker experiences with differentiated HIV treatment models in Eswatini","volume":"17","author":"Reidy","year":"2022"},{"key":"b5","series-title":"HIV AIDS (Auckl)","first-page":"539","article-title":"Experiences and perceptions on community client-led ART delivery (CCLADS) model of antiretroviral (ART) delivery: Patients\u2019 and providers\u2019 perspectives in south western Uganda","volume":"14","author":"Kasande","year":"2022"},{"key":"b6","series-title":"J Int AIDS Soc","first-page":"e25809","article-title":"Tuberculosis treatment within differentiated service delivery models in global HIV\/TB programming","volume":"24","author":"Tran","year":"2021"},{"key":"b7","series-title":"PLoS One","first-page":"e0254214","article-title":"A mixed-methods evaluation of the uptake of novel differentiated ART delivery models in a national sample of health facilities in Uganda","volume":"16","author":"Zakumumpa","year":"2021"},{"key":"b8","series-title":"BMC Health Serv Res","first-page":"222","article-title":"Understanding implementation barriers in the national scale-up of differentiated ART delivery in Uganda","volume":"20","author":"Zakumumpa","year":"2020"},{"key":"b9","series-title":"BMC Health Serv Res","first-page":"1431","article-title":"Barriers and facilitators to the implementation and scale up of differentiated service delivery models for HIV treatment in Africa: A scoping review","volume":"22","author":"Belay","year":"2022"},{"key":"b10","series-title":"BMC Health Serv Res","first-page":"1129","article-title":"Exploring drivers and barriers to the utilization of community client-led ART delivery model in South-Western Uganda: Patients\u2019 and health workers\u2019 experiences","volume":"21","author":"Kintu","year":"2021"},{"key":"b11","series-title":"J Clin Tuberc Other Mycobact Dis","first-page":"100369","article-title":"Partnering with the private laboratories to strengthen TB diagnostics in Nigeria","volume":"31","author":"Ali","year":"2023"},{"key":"b12","series-title":"BMJ Global Health","first-page":"e008661","article-title":"Engaging pharmacies in tuberculosis control: Operational lessons from 19 case detection interventions in high-burden countries","volume":"7","author":"Bigio","year":"2022"},{"key":"b13","series-title":"Int J Tuberc Lung Dis","first-page":"343","article-title":"Private pharmacy and community health worker engagement in the provision of TB services","volume":"28","author":"Semakula","year":"2024"},{"key":"b14","series-title":"J Clin Tuberc Other Mycobact Dis","first-page":"100135","article-title":"Quality of tuberculosis care by pharmacies in low- and middle-income countries: Gaps and opportunities","volume":"18","author":"Miller","year":"2020"},{"key":"b15","series-title":"Explor Res Clin Soc Pharm","first-page":"100613","article-title":"Can we involve pharmacists as direct service providers for people with tuberculosis? A narrative review of current evidence","volume":"19","author":"Mardhiyyah","year":"2025"},{"key":"b16","series-title":"BMJ Glob Health","first-page":"e013104","article-title":"Pharmacy engagement in TB prevention and care: Not if, but how?","volume":"8","author":"Miller","year":"2023"},{"key":"b17","series-title":"Int J Infect Dis","first-page":"S26","article-title":"The WHO Global Tuberculosis 2021 Report \u2013 Not so good news and turning the tide back to End TB","volume":"124","author":"Chakaya","year":"2022"},{"key":"b1","series-title":"Arch Bronconeumol","first-page":"446","article-title":"Tuberculosis-HIV co-infection: Progress and challenges after two decades of global antiretroviral treatment roll-out","volume":"56","author":"Letang","year":"2020"},{"key":"b2","series-title":"J Pharm Policy Pract","first-page":"6","article-title":"Engagement of the private pharmaceutical sector for TB control: Rhetoric or reality?","volume":"10","author":"Konduri","year":"2017"},{"key":"b3","series-title":"Curr HIV\/AIDS Rep","first-page":"2","article-title":"Feasibility and impact of community pharmacy and novel pick-up points for antiretroviral therapy pre-exposure prophylaxis initiation and continuation in low and middle-income countries","volume":"22","author":"Lalla-Edward","year":"2024"},{"key":"b4","series-title":"PLoS One","first-page":"e0269020","article-title":"Client and healthcare worker experiences with differentiated HIV treatment models in Eswatini","volume":"17","author":"Reidy","year":"2022"},{"key":"b5","series-title":"HIV AIDS (Auckl)","first-page":"539","article-title":"Experiences and perceptions on community client-led ART delivery (CCLADS) model of antiretroviral (ART) delivery: Patients\u2019 and providers\u2019 perspectives in south western Uganda","volume":"14","author":"Kasande","year":"2022"},{"key":"b6","series-title":"J Int AIDS Soc","first-page":"e25809","article-title":"Tuberculosis treatment within differentiated service delivery models in global HIV\/TB programming","volume":"24","author":"Tran","year":"2021"},{"key":"b7","series-title":"PLoS One","first-page":"e0254214","article-title":"A mixed-methods evaluation of the uptake of novel differentiated ART delivery models in a national sample of health facilities in Uganda","volume":"16","author":"Zakumumpa","year":"2021"},{"key":"b8","series-title":"BMC Health Serv Res","first-page":"222","article-title":"Understanding implementation barriers in the national scale-up of differentiated ART delivery in Uganda","volume":"20","author":"Zakumumpa","year":"2020"},{"key":"b9","series-title":"BMC Health Serv Res","first-page":"1431","article-title":"Barriers and facilitators to the implementation and scale up of differentiated service delivery models for HIV treatment in Africa: A scoping review","volume":"22","author":"Belay","year":"2022"},{"key":"b10","series-title":"BMC Health Serv Res","first-page":"1129","article-title":"Exploring drivers and barriers to the utilization of community client-led ART delivery model in South-Western Uganda: Patients\u2019 and health workers\u2019 experiences","volume":"21","author":"Kintu","year":"2021"},{"key":"b11","series-title":"J Clin Tuberc Other Mycobact Dis","first-page":"100369","article-title":"Partnering with the private laboratories to strengthen TB diagnostics in Nigeria","volume":"31","author":"Ali","year":"2023"},{"key":"b12","series-title":"BMJ Global Health","first-page":"e008661","article-title":"Engaging pharmacies in tuberculosis control: Operational lessons from 19 case detection interventions in high-burden countries","volume":"7","author":"Bigio","year":"2022"},{"key":"b13","series-title":"Int J Tuberc Lung Dis","first-page":"343","article-title":"Private pharmacy and community health worker engagement in the provision of TB services","volume":"28","author":"Semakula","year":"2024"},{"key":"b14","series-title":"J Clin Tuberc Other Mycobact Dis","first-page":"100135","article-title":"Quality of tuberculosis care by pharmacies in low- and middle-income countries: Gaps and opportunities","volume":"18","author":"Miller","year":"2020"},{"key":"b15","series-title":"Explor Res Clin Soc Pharm","first-page":"100613","article-title":"Can we involve pharmacists as direct service providers for people with tuberculosis? A narrative review of current evidence","volume":"19","author":"Mardhiyyah","year":"2025"},{"key":"b16","series-title":"BMJ Glob Health","first-page":"e013104","article-title":"Pharmacy engagement in TB prevention and care: Not if, but how?","volume":"8","author":"Miller","year":"2023"},{"key":"b17","series-title":"Int J Infect Dis","first-page":"S26","article-title":"The WHO Global Tuberculosis 2021 Report \u2013 Not so good news and turning the tide back to End TB","volume":"124","author":"Chakaya","year":"2022"}],"container-title":["The American Journal of Tropical Medicine and Hygiene"],"original-title":[],"link":[{"URL":"https:\/\/www.ajtmh.org\/view\/journals\/tpmd\/114\/1\/article-p3.xml","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.ajtmh.org\/downloadpdf\/journals\/tpmd\/114\/1\/article-p3.xml","content-type":"text\/html","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/www.ajtmh.org\/downloadpdf\/journals\/tpmd\/114\/1\/article-p3.xml","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,1,7]],"date-time":"2026-01-07T13:53:13Z","timestamp":1767793993000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.ajtmh.org\/view\/journals\/tpmd\/114\/1\/article-p3.xml"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,1,7]]},"references-count":34,"journal-issue":{"issue":"1"},"URL":"https:\/\/doi.org\/10.4269\/ajtmh.25-0477","relation":{},"ISSN":["0002-9637","1476-1645"],"issn-type":[{"value":"0002-9637","type":"print"},{"value":"1476-1645","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,1,7]]}}}